Correlation Between Enliven Therapeutics and ProMIS Neurosciences
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and ProMIS Neurosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and ProMIS Neurosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and ProMIS Neurosciences, you can compare the effects of market volatilities on Enliven Therapeutics and ProMIS Neurosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of ProMIS Neurosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and ProMIS Neurosciences.
Diversification Opportunities for Enliven Therapeutics and ProMIS Neurosciences
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Enliven and ProMIS is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and ProMIS Neurosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProMIS Neurosciences and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with ProMIS Neurosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProMIS Neurosciences has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and ProMIS Neurosciences go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and ProMIS Neurosciences
Given the investment horizon of 90 days Enliven Therapeutics is expected to under-perform the ProMIS Neurosciences. But the stock apears to be less risky and, when comparing its historical volatility, Enliven Therapeutics is 1.31 times less risky than ProMIS Neurosciences. The stock trades about -0.1 of its potential returns per unit of risk. The ProMIS Neurosciences is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 106.00 in ProMIS Neurosciences on October 26, 2024 and sell it today you would lose (13.00) from holding ProMIS Neurosciences or give up 12.26% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. ProMIS Neurosciences
Performance |
| Timeline |
| Enliven Therapeutics |
| ProMIS Neurosciences |
Enliven Therapeutics and ProMIS Neurosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and ProMIS Neurosciences
The main advantage of trading using opposite Enliven Therapeutics and ProMIS Neurosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, ProMIS Neurosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will offset losses from the drop in ProMIS Neurosciences' long position.| Enliven Therapeutics vs. Pmv Pharmaceuticals | Enliven Therapeutics vs. Cullinan Oncology LLC | Enliven Therapeutics vs. Immuneering Corp | Enliven Therapeutics vs. Aerovate Therapeutics |
| ProMIS Neurosciences vs. biOasis Technologies | ProMIS Neurosciences vs. Zenith Capital Corp | ProMIS Neurosciences vs. Hemogenyx Pharmaceuticals Plc | ProMIS Neurosciences vs. Fennec Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |